Sticking points as post-Brexit talks enter final phase
In seven months of negotiations, London and Brussels have still not been able to agree on the "governance" of the future agreement.
Latest News from Moneycontrol.com
FDA Approves Aurinia Pharmaceuticals' (Nasdaq: AUPH / TSX: AUP) LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis




